Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ameren Illinois (AILIP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ameren Illinois (AILIP) over the last 17 years, with Q3 2025 value amounting to $9.0 million.

  • Ameren Illinois' Cash & Equivalents fell 4705.88% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 4705.88%. This contributed to the annual value of $7.0 million for FY2024, which is 7200.0% down from last year.
  • Latest data reveals that Ameren Illinois reported Cash & Equivalents of $9.0 million as of Q3 2025, which was down 4705.88% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, Ameren Illinois' Cash & Equivalents peaked at $267.0 million during Q2 2021, and registered a low of $7.0 million during Q2 2023.
  • For the 5-year period, Ameren Illinois' Cash & Equivalents averaged around $77.1 million, with its median value being $23.0 million (2025).
  • In the last 5 years, Ameren Illinois' Cash & Equivalents plummeted by 9565.22% in 2023 and then soared by 75000.0% in 2024.
  • Quarter analysis of 5 years shows Ameren Illinois' Cash & Equivalents stood at $155.0 million in 2021, then plummeted by 93.55% to $10.0 million in 2022, then skyrocketed by 150.0% to $25.0 million in 2023, then tumbled by 72.0% to $7.0 million in 2024, then increased by 28.57% to $9.0 million in 2025.
  • Its Cash & Equivalents stands at $9.0 million for Q3 2025, versus $11.0 million for Q2 2025 and $23.0 million for Q1 2025.